Mandate

Vinge advises Amundi in connection with the acquisition of Lyxor Asset Management from Société Générale for EUR 825 million

Vinge has advised Amundi, a division of the Crédit Agricole group, in connection with its acquisition of Lyxor from Société Générale.

Lyxor is a pioneer within, and the third largest actor in Europe with regard to exchange‑traded funds (ETFs), and via this acquisition Amundi will thereby strengthen its position as the European lead actor in the fast‑growing market for ETFs. The transaction is subject to customary approvals by public authorities and is expected to be completed not later than February 2022.

Vinge’s team consisted of responsible partner Fredrik Wilkens (Project Manager), Henrik SchönAnton Sjökvist (Fund Issues), Åsa GotthardsonSara Strandberg and Ebba Svenburg (Employment Law), Maria Schultzberg, Henrik Wastenson and Karolin Ekström (Tax) as well as Ulf Nilsson (VAT).

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026